 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
6-6-2023
Insider Buy |
Victor F. Ganzi
Director |
$1.23
CAGR »
|
$246.00
200 shares |
6-1-2023
Insider Buy |
Victor F. Ganzi
Director |
$1.15
CAGR »
|
$19,399.29
16,808 shares |
8-24-2022
Insider Buy |
David Afshar
Chief Financial Officer |
$2.01
CAGR »
|
$20,140.00
10,000 shares |
5-26-2022
Insider Buy |
Patrick A. Cunningham
Chief Compliance Officer |
$3.10
CAGR »
|
$9,625.50
3,100 shares |
5-20-2022
Insider Buy |
Edwin C. Reisz
Chief Administrative Officer |
$2.88
CAGR »
|
$25,929.00
9,000 shares |
5-19-2022
Insider Buy |
Jeff Shaner
Chief Operating Officer |
$2.91
CAGR »
|
$26,145.00
9,000 shares |
5-19-2022
Insider Buy |
Rodney D. Windley
Director, Executive Chairman |
$2.91
CAGR »
|
$104,580.00
36,000 shares |
5-16-2022
Insider Buy |
David Afshar
Chief Financial Officer |
$2.86
CAGR »
|
$34,407.31
12,036 shares |
5-19-2022
Insider Buy |
Tony Strange
See Remarks |
$2.90
CAGR »
|
$104,544.00
36,000 shares |
5-18-2022
Insider Buy |
Steven E. Rodgers
Director |
$2.82
CAGR »
|
$101,442.00
36,000 shares |
12-15-2021
Insider Buy |
Tony Strange
See Remarks |
$6.48
CAGR »
|
$97,200.00
15,000 shares |
12-15-2021
Insider Buy |
Rodney D. Windley
Director, Executive Chairman |
$6.51
CAGR »
|
$97,650.00
15,000 shares |
12-1-2021
Insider Buy |
David Afshar
Chief Financial Officer |
$6.26
CAGR »
|
$29,809.50
4,760 shares |
11-17-2021
Insider Buy |
David Afshar
Chief Financial Officer |
$7.73
CAGR »
|
$29,760.50
3,850 shares |
8-13-2021
Insider Buy |
David Afshar
Chief Financial Officer |
$9.97
CAGR »
|
$50,547.90
5,070 shares |
4-30-2021
Insider Buy |
David Afshar
Chief Financial Officer |
$11.67
CAGR »
|
$49,994.28
4,284 shares |
4-30-2021
Insider Buy |
Jeff Shaner
Chief Operating Officer |
$11.57
CAGR »
|
$11,570.00
1,000 shares |
Also See: Institutional Holders of AVAH
Also See: SEC filings
Below we present the annualized performance delivered by Aveanna Healthcare Holdings stock since 6-6-2023 (the date of the most recent
insider purchase). The performance of the investment from the time Aveanna Healthcare Holdings insider buying occurred is the ultimate
test of whether insiders were right about AVAH being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/07/2023 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$1.38 |
|
| End price/share: |
$2.29 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
65.94% |
|
| Annualized Gain: |
75.93% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$16,594.00 |
|
| Years: |
0.87 |
|
Aveanna Healthcare Holdings Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Aveanna Healthcare Holdings insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding AVAH
|
|
Free AVAH Email Alerts:
